Here's how Bris­tol My­er­s' CEO Gio­van­ni Caforio com­plet­ed a $13B buy­out: He moved fast, upped the bid quick­ly and de­mand­ed every­one to keep up

Bris­tol My­ers Squibb CEO Gio­van­ni Caforio does not waste time. He al­so likes every­one around him to keep up.

Any­one read­ing over the in­sid­er ac­count filed with the SEC of the back-and-forth over his $13 bil­lion buy­out of MyoKar­dia $MYOK could reach on­ly one con­clu­sion: The CEO who had will­ing­ly craft­ed a $74 bil­lion Cel­gene ac­qui­si­tion had found some­thing else he liked — and he was will­ing to pay a nice pre­mi­um to get it.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER